Advertisement

Archives of Dermatological Research

, Volume 311, Issue 4, pp 309–315 | Cite as

Association of GA genotype of SNP rs4680 in COMT gene with psoriasis

  • Vladimir Sobolev
  • Luiza Sakaniya
  • Artemii Tretiakov
  • Zarema Kokaeva
  • Elena Naumova
  • Olga Rudko
  • Anna Soboleva
  • Ivan Danilin
  • Irina Korsunskaya
  • Eugene KlimovEmail author
Original Paper
  • 67 Downloads

Abstract

Psoriasis is a multigene and multifactorial skin disease with heterogeneous genetic inheritance. Mental disorders participate in the development of psoriasis as predisposing factors; a correlation of dermatological diseases with pathological anxiety and stress was shown. Meanwhile, there are no studies describing molecular mechanisms of the linkages between psycho-emotional disorders and skin diseases. The aim of this study is to find the associations between SNP in genes COMT (rs4680), DBH (rs141116007), CCKAR (rs1800857) and CCKBR (rs1805002), and psoriasis. Patients were selected according to the 10th revision of International Classification of Diseases (L-40). The sample size was 88 patients. The size of the control sample (population control) was 365 people. Genotyping was performed using PCR-RFLP and real-time PCR. Statistical analysis was performed using WinPepi software. Identification of complex genotypes was performed by the Monte Carlo method using APSampler 3.6.1 algorithm. Among the studied genes, only GA genotype of COMT gene is significantly associated with psoriasis [χ2 = 19.163 (p = 1.3E−5), F (p) = 1.2E−5, OR 3.47 (CI 99% = 1.61–7.91)]. At the moment, the functional significance of this phenomenon is difficult to explain.

Keywords

Psychodermatology Psoriasis Genes COMT DBH CCKAR CCKBR Polymorphism Genotyping Genetic associations 

Notes

Acknowledgements

We would like to thank all patients for their participation in this study. We would also like to thank Ekaterina Gapanovich, Liubov Korobeynikova and Alena Malakhova for helping us provide molecular genetic analysis. This research received no specific Grant from any funding agency in the public, commercial, or not-for-profit sectors.

Funding

This research received no specific Grant from any funding agency in the public, commercial, or not-for-profit sectors.

Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest.

References

  1. 1.
    Abramson JH (2011) WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol Perspect Innov 8:1.  https://doi.org/10.1186/1742-5573-8-1 CrossRefGoogle Scholar
  2. 2.
    Afonchikova E, Azimova JE, Fokina NM, Kokaeva ZG, Kochetkova TO, Kondratieva NS, Rudko OI, Tabeeva GR, Klimov EA (2013) Association of MAOA, CCK, COMT, TPH1, SERT, PDE4B with panic disorder in patients from the Moscow population. Febs J 280:343–344Google Scholar
  3. 3.
    Brown DG (1972) Stress as a precipitant factor of eczema. J Psychosom Res 16:321–327CrossRefGoogle Scholar
  4. 4.
    Cubells JF, Kranzler HR, McCance-Katz E, Anderson GM, Malison RT, Price LH, Gelernter J (2000) A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry 5:56–63CrossRefGoogle Scholar
  5. 5.
    Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C (2009) Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 37:e67.  https://doi.org/10.1093/nar/gkp215 CrossRefGoogle Scholar
  6. 6.
    Devrimci-Ozguven H, Kundakci TN, Kumbasar H, Boyvat A (2000) The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol JEADV 14:267–271CrossRefGoogle Scholar
  7. 7.
    Elder JT, Nair RP, Henseler T, Jenisch S, Stuart P, Chia N, Christophers E, Voorhees JJ (2001) The genetics of psoriasis 2001: the odyssey continues. Arch Dermatol 137:1447–1454CrossRefGoogle Scholar
  8. 8.
    Erdal ME, Tursen U, Kaya TI, Kanik A, Derici E, Ikizoglu G (2004) Association between catechol-O-methyltransferase polymorphism and psoriasis. Int J Dermatol 43:312–314.  https://doi.org/10.1111/j.1365-4632.2004.01992.x CrossRefGoogle Scholar
  9. 9.
    Favorov AV, Andreewski TV, Sudomoina MA, Favorova OO, Parmigiani G, Ochs MF (2005) A Markov chain Monte Carlo technique for identification of combinations of allelic variants underlying complex diseases in humans. Genetics 171:2113–2121.  https://doi.org/10.1534/genetics.105.048090 CrossRefGoogle Scholar
  10. 10.
    Gao L, Li H, Li K, Shen Z, Liu L, Li C, Zhang Z, Liu Y (2009) Polymorphism of the catechol-O-methyltransferase gene in Han Chinese patients with psoriasis vulgaris. Genet Mol Biol 32:32–36.  https://doi.org/10.1590/S1415-47572009005000002 CrossRefGoogle Scholar
  11. 11.
    Garshick MK, Kimball AB (2015) Psoriasis and the life cycle of persistent life effects. Dermatol Clin 33:25–39.  https://doi.org/10.1016/j.det.2014.09.003 CrossRefGoogle Scholar
  12. 12.
    Guerra-Tapia A, Asensio Martinez A, Garcia Campayo J (2015) The emotional impact of skin diseases. Actas Dermo Sifiliogr 106:699–702.  https://doi.org/10.1016/j.ad.2015.06.002 CrossRefGoogle Scholar
  13. 13.
    Harden JL, Krueger JG, Bowcock AM (2015) The immunogenetics of psoriasis: a comprehensive review. J Autoimmun 64:66–73.  https://doi.org/10.1016/j.jaut.2015.07.008 CrossRefGoogle Scholar
  14. 14.
    Hunter HJ, Griffiths CE, Kleyn CE (2013) Does psychosocial stress play a role in the exacerbation of psoriasis? Br J Dermatol 169:965–974.  https://doi.org/10.1111/bjd.12478 CrossRefGoogle Scholar
  15. 15.
    Iizuka H, Umeda K, Koizumi H, Aoyagi T, Miura Y (1981) Epinephrine-induced cyclic AMP accumulation in the psoriatic epidermis. Acta Derm Venereol 61:391–395Google Scholar
  16. 16.
    Ionescu G, Kiehl R (1991) Increased plasma norepinephrine in psoriasis. Acta Derm Venereol 71:169–170Google Scholar
  17. 17.
    Kato T, Wang ZW, Zoega T, Crowe RR (1996) Missense mutation of the cholecystokinin B receptor gene: lack of association with panic disorder. Am J Med Genet 67:401–405.  https://doi.org/10.1002/(SICI)1096-8628(19960726)67:4%3C401::AID-AJMG14%3E3.0.CO;2-N CrossRefGoogle Scholar
  18. 18.
    Korobeynikova LA, Rudko OI, Azimova YE, Fokina NM, Klimov EA (2012) Genetic basis of predisposition to panic disorder. Biol Bull Rev 2:294–305.  https://doi.org/10.1134/S2079086412040056 CrossRefGoogle Scholar
  19. 19.
    Leon A, Levin EC, Koo JY (2013) Psychodermatology: an overview. Semin Cutan Med Surg 32:64–67CrossRefGoogle Scholar
  20. 20.
    Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J (1995) Kinetics of human soluble and membrane-bound catechol-O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202–4210CrossRefGoogle Scholar
  21. 21.
    Magina S, Moura E, Serrao MP, Moura D, Vieira-Coelho MA (2013) Catechol-O-methyltransferase activity is higher in psoriasis patients and is down-regulated by narrowband ultraviolet B treatment. Eur J Dermatol 23:49–52.  https://doi.org/10.1684/ejd.2012.1912 Google Scholar
  22. 22.
    Ni C, Chiu MW (2014) Psoriasis and comorbidities: links and risks. Clin Cosmet Investig Dermatol 7:119–132.  https://doi.org/10.2147/CCID.S44843 Google Scholar
  23. 23.
    Rieder E, Tausk F (2012) Psoriasis, a model of dermatologic psychosomatic disease: psychiatric implications and treatments. Int J Dermatol 51:12–26.  https://doi.org/10.1111/j.1365-4632.2011.05071.x CrossRefGoogle Scholar
  24. 24.
    Rutherford K, Alphandery E, McMillan A, Daggett V, Parson WW (2008) The V108M mutation decreases the structural stability of catechol-O-methyltransferase. Biochim Biophys Acta 1784:1098–1105.  https://doi.org/10.1016/j.bbapap.2008.04.006 CrossRefGoogle Scholar
  25. 25.
    Rutherford K, Le Trong I, Stenkamp RE, Parson WW (2008) Crystal structures of human 108V and 108M catechol-O-methyltransferase. J Mol Biol 380:120–130.  https://doi.org/10.1016/j.jmb.2008.04.040 CrossRefGoogle Scholar
  26. 26.
    Schell C, Schleich R, Walker F, Yazdi AS, Lerche H, Rocken M, Axmann D, Ghoreschi K, Eberle FC (2015) Restless legs syndrome in psoriasis: an unexpected comorbidity. Eur J Dermatol 25:255–260.  https://doi.org/10.1684/ejd.2015.2525 Google Scholar
  27. 27.
    Sobolev VV, Starodubtseva NL, Piruzyan AL, Minnibaev MT, Sautin ME, Tumanov VP, Bruskin SA (2011) Comparative study of the expression of ATF-3 and ATF-4 genes in vessels involved into atherosclerosis process and in psoriatic skin. Bull Exp Biol Med 151:713–716CrossRefGoogle Scholar
  28. 28.
    Souteiro P, Vieira-Coelho MA, Serrao MP, Magina S (2013) Catechol-O-methyltransferase activity in psoriasis patients treated with psoralen plus ultraviolet A therapy. Photodermatol Photoimmunol Photomed 29:227–232.  https://doi.org/10.1111/phpp.12058 CrossRefGoogle Scholar
  29. 29.
    Wong JW, Koo JY (2013) Psychopharmacological therapies in dermatology. Dermatol Online J 19:18169Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Vladimir Sobolev
    • 1
    • 2
    • 3
  • Luiza Sakaniya
    • 1
  • Artemii Tretiakov
    • 4
  • Zarema Kokaeva
    • 4
  • Elena Naumova
    • 4
  • Olga Rudko
    • 4
  • Anna Soboleva
    • 1
  • Ivan Danilin
    • 5
  • Irina Korsunskaya
    • 1
  • Eugene Klimov
    • 3
    • 4
    • 6
    Email author
  1. 1.Centre of Theoretical Problems of Physico-Chemical PharmacologyRussian Academy of SciencesMoscowRussia
  2. 2.I.I. Mechnikov Research Institute for Vaccines and SeraMoscowRussia
  3. 3.University Diagnostic Laboratory, LLCMoscowRussia
  4. 4.Faculty of Biology, Lomonosov Moscow State UniversityMoscowRussia
  5. 5.Peoples’ Friendship University of RussiaMoscowRussia
  6. 6.Center of Experimental Embryology and Reproductive BiotechnologiesMoscowRussia

Personalised recommendations